ClinicalTrials.gg
Drug

Almorexant clinical trials

studies test it
4
open now
0
in phase 3
1
first study started
2006

How each study uses almorexant is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

almorexant
3

Development codes

ACT-078573
1

Studies by the year they started

4 studies that test it; most in 2006 (1)

Studies that test almorexant, by start year
YearStudies
20061
20081
20091
20111

By phase

A phase 1/2 study counts in both.

Phase 1
2
Phase 3
1
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 3 · Other 1

Midnight Pharma, LLC (3) · Northern California Institute of Research and Education (1)

Studies

Open first, then newest update. How each study uses almorexant is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 4

Given beside what is tested · 1 — almorexant is usual care or a partner of the new treatment

Codes

What other systems call almorexant · ClinicalTrials.gg INT005073

  • MeSH (NLM) C519150almorexantOne source NLM
  • UNII (FDA) 9KCW39P2EIALMOREXANTConfirmed FDA, NLM, Wikidata
  • Wikidata Q4355941almorexantConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C87423AlmorexantOne source FDA
  • DrugBank DB06673One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.